Jane Street’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $737K | Buy |
+9,037
| New | +$653K | ﹤0.01% | 7181 |
|
|
2026
Q1 | – | Sell |
-3,925
| Closed | -$278K | – | 12703 |
|
|
2025
Q4 | $298K | Sell |
3,925
-96,281
| -96% | -$7M | ﹤0.01% | 8852 |
|
|
2025
Q3 | $6.15M | Buy |
100,206
+50,985
| +104% | +$2.66M | ﹤0.01% | 3110 |
|
|
2025
Q2 | $2.4M | Sell |
49,221
-109,409
| -69% | -$5.19M | ﹤0.01% | 4130 |
|
|
2025
Q1 | $8.08M | Sell |
158,630
-7,288
| -4% | -$364K | ﹤0.01% | 2266 |
|
|
2024
Q4 | $7.49M | Sell |
165,918
-72,790
| -30% | -$3.12M | ﹤0.01% | 2175 |
|
|
2024
Q3 | $8.86M | Sell |
238,708
-103,122
| -30% | -$3.45M | ﹤0.01% | 2054 |
|
|
2024
Q2 | $10.5M | Buy |
341,830
+247,141
| +261% | +$8.01M | ﹤0.01% | 2010 |
|
|
2024
Q1 | $2.75M | Sell |
94,689
-723,169
| -88% | -$20.3M | ﹤0.01% | 3541 |
|
|
2023
Q4 | $22.5M | Buy |
817,858
+638,134
| +355% | +$14.6M | 0.01% | 1171 |
|
|
2023
Q3 | $4.03M | Buy |
179,724
+39,222
| +28% | +$1.46M | ﹤0.01% | 2922 |
|
|
2023
Q2 | $5.71M | Buy |
140,502
+108,374
| +337% | +$5.3M | ﹤0.01% | 2550 |
|
|
2023
Q1 | $1.56M | Buy |
32,128
+24,630
| +328% | +$1.13M | ﹤0.01% | 4244 |
|
|
2022
Q4 | $286K | Sell |
7,498
-23,322
| -76% | -$970K | ﹤0.01% | 7100 |
|
|
2022
Q3 | $1.55M | Sell |
30,820
-12,091
| -28% | -$592K | ﹤0.01% | 4628 |
|
|
2022
Q2 | $1.72M | Buy |
42,911
+30,534
| +247% | +$1.07M | ﹤0.01% | 4449 |
|
|
2022
Q1 | $462K | Buy |
12,377
+3,087
| +33% | +$119K | ﹤0.01% | 7636 |
|
|
2021
Q4 | $369K | Sell |
9,290
-2,286
| -20% | -$87.5K | ﹤0.01% | 7792 |
|
|
2021
Q3 | $431K | Buy |
+11,576
| New | +$476K | ﹤0.01% | 7561 |
|
|
2021
Q2 | – | Sell |
-20,292
| Closed | -$869K | – | 10279 |
|
|
2021
Q1 | $961K | Sell |
20,292
-3,244
| -14% | -$193K | ﹤0.01% | 5528 |
|
|
2020
Q4 | $1.44M | Sell |
23,536
-9,871
| -30% | -$582K | ﹤0.01% | 4071 |
|
|
2020
Q3 | $1.56M | Sell |
33,407
-52,574
| -61% | -$2.59M | ﹤0.01% | 3397 |
|
|
2020
Q2 | $4.36M | Buy |
85,981
+79,581
| +1,243% | +$3.91M | ﹤0.01% | 2018 |
|
|
2020
Q1 | $285K | Sell |
6,400
-3,356
| -34% | -$169K | ﹤0.01% | 4264 |
|
|
2019
Q4 | $469K | Sell |
9,756
-3,595
| -27% | -$153K | ﹤0.01% | 3764 |
|
|
2019
Q3 | $452K | Buy |
13,351
+8,453
| +173% | +$368K | ﹤0.01% | 3658 |
|
|
2019
Q2 | $220K | Sell |
4,898
-3,821
| -44% | -$151K | ﹤0.01% | 4596 |
|
|
2019
Q1 | $328K | Buy |
+8,719
| New | +$293K | ﹤0.01% | 4157 |
|
|
2018
Q4 | – | Sell |
-15,306
| Closed | -$719K | – | 5540 |
|
|
2018
Q3 | $719K | Buy |
+15,306
| New | +$633K | ﹤0.01% | 3170 |
|
|
2018
Q2 | – | Sell |
-21,790
| Closed | -$590K | – | 5481 |
|
|
2018
Q1 | $590K | Buy |
+21,790
| New | +$552K | ﹤0.01% | 3294 |
|
|
2017
Q4 | – | Sell |
-78,768
| Closed | -$1.58M | – | 5060 |
|
|
2017
Q3 | $1.58M | Buy |
+78,768
| New | +$1.54M | 0.01% | 1823 |
|
|
2016
Q3 | – | Sell |
-13,669
| Closed | -$111K | – | 4408 |
|
|
2016
Q2 | $96K | Sell |
13,669
-41,446
| -75% | -$304K | ﹤0.01% | 3897 |
|
|
2016
Q1 | $355K | Buy |
55,115
+48,690
| +758% | +$845K | ﹤0.01% | 3020 |
|
|
2015
Q4 | $208K | Buy |
+6,425
| New | +$189K | ﹤0.01% | 3546 |
|
|
2015
Q2 | – | Sell |
-7,633
| Closed | -$465K | – | 3948 |
|
|
2015
Q1 | $465K | Buy |
+7,633
| New | +$466K | ﹤0.01% | 2120 |
|
|
2014
Q3 | – | Sell |
-17,947
| Closed | -$469K | – | 2949 |
|
|
2014
Q2 | $469K | Buy |
+17,947
| New | +$384K | 0.01% | 1466 |
|
Other funds holding PTCT
RI
JT
Jane Street's PTCT Position: Q2 2026 in Review
Jane Street opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 9,037 shares worth $737K. The stake represents ﹤0.01% of the portfolio and ranks #7181 among its holdings. This is a return to the name: Jane Street previously reported a position in PTCT as recently as Q4 2025.
Jane Street first reported a position in PTCT in Q2 2014 and has held it in 36 quarters since. The position peaked at $22.5M in Q4 2023. 379 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Jane Street held 9,037 shares of PTC Therapeutics worth $737K as of Q2 2026.
- PTC Therapeutics was a new Jane Street position in Q2 2026.
- PTC Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7181 holding.
- Jane Street first reported a position in PTC Therapeutics in Q2 2014 and has held it in 36 quarters since.
- Jane Street's PTC Therapeutics position peaked at $22.5M in Q4 2023.
- 379 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.